Advanced search×

Effects of mono- and dual blockade of the renin-angiotensin system on markers of cardiovascular status in hypertensive patients with mild and moderate renal failure.

Gábor Nagy, István A Szijártó, Balázs Gaszner, Eva Lányi, Lajos Markó, Akos Mérei, Gergő A Molnár, Kinga Németh, József Betlehem, and István Wittmann

Kidney Blood Press Res 34(3):150-7 (2011) PMID 21372591

Dual renin-angiotensin system (RAS) blockade has no more efficiency to decrease cardiovascular mortality than mono-blockade. Our goal was to explore differences between other cardiovascular markers in patients with RAS blockade.

DOI: 10.1159/000324465
Version: za2963e q8zaf q8zba q8zc2 q8zd9 q8ze0 q8zf0 q8zgc
Buy PDF

Similar articles you may find interesting…

  1. PEP-1-CAT protects hypoxia/reoxygenation-induced cardiomyocyte apoptosis through multiple sigaling pathways.
    Lei Zhang, Shuang Wei, and Jia-Ning Wang

    J Transl Med 11(1):113 (2013) PMID 23642335

    PEP-1-CAT protected H9c2 from H/R-induced morphological alteration and reduced the release of lactate dehydrogenase (LDH) and malondialdehyde content. Superoxide anion production was also decreased. In addition, PEP-1-CAT inhibited H9c2 apoptosis and blocked the expression of apoptosis stimulator Ba...
    PDF not found
  2. Dual-Task Effect on Gait Balance Control in Concussed Adolescents.
    David R Howell, Louis R Osternig, and Li-Shan Chou

    Arch Phys Med Rehabil (2013) PMID 23643687

    No between-group differences were observed for step length and step width. The dual-task cost for average walking speed for concussed subjects was greater than control subjects across the two month testing period (main effect of group p = .019), as were the dual-task costs for peak anterior COM velo...
    Buy PDF
  3. Cardiac toxicity in breast cancer patients treated with dual HER2 blockade.
    Antonis Valachis, Andreas Nearchou, and Pehr Lind

    Int J Cancer (2013) PMID 23629633

    We conducted a meta-analysis of randomized trials to investigate the risk of cardiac adverse events when a combination of anti-HER2 therapies compared to anti-HER2 monotherapy. We searched Medline, the Cochrane library, as well as the electronic abstract databases of the major international congress...
    Buy PDF